<DOC>
	<DOCNO>NCT00292734</DOCNO>
	<brief_summary>Primary objective : To show combination Zolpidem + antidepressant therapy effective treatment secondary insomnia depressive dysthimic patient antidepressant therapy alone acute phase disease .</brief_summary>
	<brief_title>STILDEP : Zolpidem Depressive Dysthimic Patients</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Depressive dysthimic patient acute phase mild moderate severity Depressive dysthimic patient suffer secondary insomnia ( DSM IV ) recent antidepressant therapy ( le 1 week ) Regularly use sleep pill last 23 month Use sleeping pils last week Insufficient hepatic Myasthenia gravis Proven hypersensivity Zolpidem Evidence clinically relevant nervous system disorder ( neurologic/psychiatric disease associate depression ) History evidence alcohol drug abuse Evidence clinically relevant cardiovascular , haematologic , hepatic , gastrointestinal , renal , pulmonary endocrinologic disease Abnormal snore Work alternate shift Suffering periodic leg movement disorder sleep apnea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>